Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NOX Announcements
SOF-SKN manufacturing begins to ensure…
NOX
NOXOPHARM LIMITED
Market sensitive
SOF-SKN manufacturing begins to ensure clinical trial readi
Date and time
9 June 2026 at 6:29 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
NOX announcement history
Recent NOX announcements
New study further validates Noxopharms cancer pipeline
Quarterly Activities/Appendix 4C Cash Flow Report
Pre-IND meeting request with US FDA
Sofr platform versatility shown via childbirth MRFF grant
Fast-tracking of cancer program via novel animal model
Change of Director's Interest Notice